Cargando…

Analysis of Clinical Features and Next-Generation Sequencing of 12 Tuberous Sclerosis Families in China

BACKGROUND: Tuberous sclerosis complex (TSC) is a rare autosomal dominant genetic disease with systemic organ involvement. So far, only a few TSC families in China have been reported. Therefore, more data on the clinical and genetic features of TSC families are required. MATERIALS AND METHODS: We re...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xu, Wang, Wenda, Zhao, Yang, Wang, Zhan, Zhang, Yushi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9197381/
https://www.ncbi.nlm.nih.gov/pubmed/35712104
http://dx.doi.org/10.3389/fmed.2022.840709
_version_ 1784727393276002304
author Wang, Xu
Wang, Wenda
Zhao, Yang
Wang, Zhan
Zhang, Yushi
author_facet Wang, Xu
Wang, Wenda
Zhao, Yang
Wang, Zhan
Zhang, Yushi
author_sort Wang, Xu
collection PubMed
description BACKGROUND: Tuberous sclerosis complex (TSC) is a rare autosomal dominant genetic disease with systemic organ involvement. So far, only a few TSC families in China have been reported. Therefore, more data on the clinical and genetic features of TSC families are required. MATERIALS AND METHODS: We retrospectively analyzed 12 TSC family probands and their family members. Next-generation sequencing (NGS) has been applied to confirm the type of TSC mutation along with a detailed physical examination. RESULTS: In this study, twenty-seven patients in 12 TSC families were reported, including 12 male and 15 female patients, aged 8–67 years. Skin lesions were detected among all patients with TSC, including 25 cases of facial angiofibromas, 18 cases of hypomelanotic macules, 15 cases of ungual fibromas, and 13 cases of shagreen patch. Other clinical features were also revealed: 14 cases of renal angiomyolipoma, 6 cases of subependymal nodules (SENs), and 3 cases of lymphangioleiomyomatosis. All twenty-seven patients with TSC were tested by NGS. Totally, TSC2 mutations were reported in 19 cases (7 frameshift mutations, 10 nonsense mutations, and 2 missense mutations), TSC1 mutations were reported in 4 cases (4 nonsense mutations), and 4 cases were genetically negative. The novel causal mutations (TSC2: c.208dup, c.1874C > G, c.1852del) identified in three families were first reported in TSC. CONCLUSION: Our findings expand the mutation spectrum of patients with TSC in China. The clinical characteristics can vary among patients with TSC with the same pathogenic mutation. The genetic results and summary of clinical features of 12 TSC families contribute to a more accurate diagnosis and further genetic counseling.
format Online
Article
Text
id pubmed-9197381
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-91973812022-06-15 Analysis of Clinical Features and Next-Generation Sequencing of 12 Tuberous Sclerosis Families in China Wang, Xu Wang, Wenda Zhao, Yang Wang, Zhan Zhang, Yushi Front Med (Lausanne) Medicine BACKGROUND: Tuberous sclerosis complex (TSC) is a rare autosomal dominant genetic disease with systemic organ involvement. So far, only a few TSC families in China have been reported. Therefore, more data on the clinical and genetic features of TSC families are required. MATERIALS AND METHODS: We retrospectively analyzed 12 TSC family probands and their family members. Next-generation sequencing (NGS) has been applied to confirm the type of TSC mutation along with a detailed physical examination. RESULTS: In this study, twenty-seven patients in 12 TSC families were reported, including 12 male and 15 female patients, aged 8–67 years. Skin lesions were detected among all patients with TSC, including 25 cases of facial angiofibromas, 18 cases of hypomelanotic macules, 15 cases of ungual fibromas, and 13 cases of shagreen patch. Other clinical features were also revealed: 14 cases of renal angiomyolipoma, 6 cases of subependymal nodules (SENs), and 3 cases of lymphangioleiomyomatosis. All twenty-seven patients with TSC were tested by NGS. Totally, TSC2 mutations were reported in 19 cases (7 frameshift mutations, 10 nonsense mutations, and 2 missense mutations), TSC1 mutations were reported in 4 cases (4 nonsense mutations), and 4 cases were genetically negative. The novel causal mutations (TSC2: c.208dup, c.1874C > G, c.1852del) identified in three families were first reported in TSC. CONCLUSION: Our findings expand the mutation spectrum of patients with TSC in China. The clinical characteristics can vary among patients with TSC with the same pathogenic mutation. The genetic results and summary of clinical features of 12 TSC families contribute to a more accurate diagnosis and further genetic counseling. Frontiers Media S.A. 2022-05-27 /pmc/articles/PMC9197381/ /pubmed/35712104 http://dx.doi.org/10.3389/fmed.2022.840709 Text en Copyright © 2022 Wang, Wang, Zhao, Wang and Zhang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Medicine
Wang, Xu
Wang, Wenda
Zhao, Yang
Wang, Zhan
Zhang, Yushi
Analysis of Clinical Features and Next-Generation Sequencing of 12 Tuberous Sclerosis Families in China
title Analysis of Clinical Features and Next-Generation Sequencing of 12 Tuberous Sclerosis Families in China
title_full Analysis of Clinical Features and Next-Generation Sequencing of 12 Tuberous Sclerosis Families in China
title_fullStr Analysis of Clinical Features and Next-Generation Sequencing of 12 Tuberous Sclerosis Families in China
title_full_unstemmed Analysis of Clinical Features and Next-Generation Sequencing of 12 Tuberous Sclerosis Families in China
title_short Analysis of Clinical Features and Next-Generation Sequencing of 12 Tuberous Sclerosis Families in China
title_sort analysis of clinical features and next-generation sequencing of 12 tuberous sclerosis families in china
topic Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9197381/
https://www.ncbi.nlm.nih.gov/pubmed/35712104
http://dx.doi.org/10.3389/fmed.2022.840709
work_keys_str_mv AT wangxu analysisofclinicalfeaturesandnextgenerationsequencingof12tuberoussclerosisfamiliesinchina
AT wangwenda analysisofclinicalfeaturesandnextgenerationsequencingof12tuberoussclerosisfamiliesinchina
AT zhaoyang analysisofclinicalfeaturesandnextgenerationsequencingof12tuberoussclerosisfamiliesinchina
AT wangzhan analysisofclinicalfeaturesandnextgenerationsequencingof12tuberoussclerosisfamiliesinchina
AT zhangyushi analysisofclinicalfeaturesandnextgenerationsequencingof12tuberoussclerosisfamiliesinchina